Four 20 Pharma
About Four 20 Pharma
Four 20 Pharma is a German pharmaceutical company specializing in the production and distribution of EU-GMP-certified medical cannabis. Operating from Dortmund, the company sources cannabis from qualified international producers and manufactures finished pharmaceutical products for the German market. Four 20 Pharma holds a narcotics manufacturing license and is one of the leading pharmaceutical cannabis companies in Germany.
Key Facts
- 1Holds a German narcotics manufacturing and distribution license
- 2All products are EU-GMP certified and pharmacy-ready
- 3Sources from qualified producers in Canada, Portugal, and Africa
- 4Became part of Curaleaf International through acquisition
Frequently Asked Questions
What does EU-GMP certification mean for Four 20 Pharma?
EU-GMP (Good Manufacturing Practice) certification means Four 20 Pharma's production processes meet the European standard for pharmaceutical manufacturing, ensuring consistent quality, safety, and traceability of all cannabis products.
Is Four 20 Pharma part of a larger company?
Four 20 Pharma was acquired by Curaleaf International (formerly EMMAC Life Sciences), making it part of one of the world's largest cannabis companies with a strong European footprint.
More Cannabis Companies in Dortmund
Cannabis Laws
Products
- EU-GMP medical cannabis flowers
- Cannabis extracts
- Pharmaceutical cannabis preparations
Specialties
Company Details
- Location
- Dortmund, Germany
- Founded
- 2017
- Publicly Traded
- No